Status:
COMPLETED
Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults
Lead Sponsor:
Pharmanex
Collaborating Sponsors:
Dermatology Consulting Services, High Point NC
Conditions:
Skin Health
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
Consumption of dietary supplements has been found to modulate skin health. Individual ingredients such as collagen peptides, lutein and ceramides have been shown to improve skin health. Collagen pepti...
Detailed Description
Visit 1 Screening (day -30 to -1): Subjects will be given a copy of the informed consent document. They will be given ample time to read and formulate questions prior to reviewing the document with st...
Eligibility Criteria
Inclusion
- Males and females 40 - 60 years of age
- Individuals must present with stable moderate signs of aging that does not change between the screening visit and the baseline visit 4 weeks later
- Subject is willing and able to participate in all aspects of the study
- Individuals must sign informed consent, photo release consent and confidentiality agreement
- Subject has a BMI \> 19 and \< 32
- Subject must be on a stable dose of chronic use medications for at least 3 months prior to study participation
- Subject who, in the opinion of the investigator, are free of any medical condition(s) that may interfere with study participation or affect study measures
Exclusion
- Individuals that are being treated for cancer or have a history of facial skin cancer
- Individuals with sunburn, moderate to pronounced suntan, uneven skin tones, tattoos, scares or other disfiguration, dilated vessels or other conditions on the test area that might influence the test results
- Any disease or condition of the skin that the investigator deems inappropriate for participation, including rosacea, eczema, psoriasis, and atopic dermatitis
- Individuals currently taking medications which in the opinion of the investigator may interfere with the study. This would include but not be limited to all oral corticosteroids, use of anti-inflammatory drugs more than 14 consecutive days, immunosuppressive drugs or antihistamine medications (steroid nose drops and/or eye drops are permitted), hormone replacement therapy and insulin, antibiotics or other topical drugs at the test sites
- Individuals with uncontrolled metabolic diseases such as diabetes (type I and II), hypertension, hyperthyroidism or hypothyroidism, severe chronic asthma, immunological disorders such as HIV, AIDS and systemic lupus erythematosus or mastectomy for cancer involving removal of lymph nodes
- Subject is taking skin, nail, and hair health promoting supplement orally (including products containing collagen and carotenoids)
- Women known to be pregnant, nursing, or planning to become pregnant
- Individuals participating in other facial clinical trials
- Individuals who have routinely used alpha-hydroxy-acid (AHA) or a beta-hydroxy-acid (BHA) containing product within two weeks of baseline visit or Retin-A®, Retin-A Micro®, Renova®, Differin®, Avita®, Tazorac®, or Soriatane® within one month of baseline visit or have taken Accutane® within one year of baseline visit. Individuals who have used Retinol in the last six months prior to baseline visit
- Individuals with inflammatory acne lesions (i.e., papules, pustules, cysts, nodules) at the test site
- Individuals who have had chemical peels or dermabrasion within the last six months prior to baseline visit
- Individuals who have sun tanned (sun or tanning beds) in the nude within the past 1 year prior to baseline visit
- Excessive alcohol use (\>2 drinks per day)
- Subject is a current smoker or quit less than 3 years from screening visit
- History of substance abuse
Key Trial Info
Start Date :
January 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03771807
Start Date
January 14 2020
End Date
June 20 2020
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Consulting Services
High Point, North Carolina, United States, 27262